LFG
CGON icon

Larson Financial Group’s CG Oncology CGON Stock Holding History

Larson Financial Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98K Sell
56
-6
-10% -$392 ﹤0.01% 2866
2026
Q1 		$4.2K Buy
62
+28
+82% +$1.59K ﹤0.01% 2679
2025
Q4 		$1.41K Buy
34
+30
+750% +$1.24K ﹤0.01% 2856
2025
Q3 		$161 Sell
4
-346
-99% -$10.1K ﹤0.01% 3284
2025
Q2 		$9.1K Buy
350
+335
+2,233% +$8.07K ﹤0.01% 1854
2025
Q1 		$367 Buy
+15
New +$422 ﹤0.01% 2654

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Larson Financial Group's CGON Position: Q2 2026 in Review

Larson Financial Group reduced its CG Oncology (CGON) stake by 9.7% in Q2 2026, selling an estimated $392 and leaving 56 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

Larson Financial Group first reported a position in CGON in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.1K in Q2 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Larson Financial Group held 56 shares of CG Oncology worth $3.98K as of Q2 2026.
  • Larson Financial Group sold 6 CG Oncology shares in Q2 2026, an estimated $392.
  • CG Oncology made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2866 holding.
  • Larson Financial Group first reported a position in CG Oncology in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's CG Oncology position peaked at $9.1K in Q2 2025.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.